US Broker Ratings

Lantheus Holdings, Inc. (LNTH) Stock Analysis: A Strong Buy with a 14% Upside Potential

Lantheus Holdings, Inc. (NASDAQ: LNTH) continues to capture investor attention with its robust portfolio of diagnostic and therapeutic products aimed at enhancing the detection and treatment of significant health issues..

GE HealthCare Technologies Inc. (GEHC): Analyst Consensus Points to Significant 31.48% Upside Potential

GE HealthCare Technologies Inc. (GEHC), a key player in the healthcare sector, stands at the forefront of the medical devices industry, drawing investor attention with its promising growth prospects. With..

BrightSpring Health Services, I (BTSG)

⚠️ No article content returned.

..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: A Promising Biotech Play with 32.74% Potential Upside

For investors with an eye on the biotechnology sector, Halozyme Therapeutics, Inc. (NASDAQ: HALO) presents a compelling opportunity. With a market capitalization of $7.51 billion, this innovative company is making..

ADMA Biologics Inc (ADMA) Stock Analysis: A Biotech Gem with 69% Upside Potential

ADMA Biologics Inc (NASDAQ: ADMA), a burgeoning player in the biotech sector, has caught the attention of investors with its promising growth trajectory and significant upside potential. Headquartered in Ramsey,..

TransMedics Group, Inc. (TMDX) Stock Analysis: Exploring a 28.69% Potential Upside in the Innovative Medical Devices Sector

TransMedics Group, Inc. (NASDAQ: TMDX), a prominent player in the medical devices industry, is captivating investor interest with its cutting-edge solutions in organ transplant therapy. With a market capitalization of..

Cardinal Health, Inc. (CAH)

⚠️ No article content returned.

..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Unveiling a Promising 171.90% Potential Upside

Telix Pharmaceuticals Limited (ASX: TLX), a dynamic player in the biotechnology sector, is catching the eye of investors with an impressive potential upside of 171.90%. As a commercial-stage biopharmaceutical company,..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Unveiling a 23.29% Upside Potential in the Medical Devices Sector

Bio-Rad Laboratories, Inc. (BIO), a prominent player in the healthcare sector specializing in medical devices, is drawing significant attention from investors with its promising upside potential. Headquartered in Hercules, California,..

Glaukos Corporation (GKOS) Stock Analysis: Exploring a 38.93% Potential Upside

Glaukos Corporation (NYSE: GKOS) has emerged as a notable player in the healthcare sector, specifically within the medical devices industry. Based in Aliso Viejo, California, this ophthalmic pharmaceutical and medical..

Medtronic plc (MDT) Stock Analysis: Navigating a 27.82% Potential Upside

For individual investors with an eye on the healthcare sector, Medtronic plc (NYSE: MDT) presents a compelling opportunity amidst the dynamic medical devices industry. Headquartered in Galway, Ireland, and boasting..

Royalty Pharma plc (RPRX) Stock Analysis: A Robust Biopharma Royalty Player with a Potential 12.94% Upside

Royalty Pharma plc (NASDAQ: RPRX) is a compelling player in the biopharmaceutical industry, strategically positioned as a major buyer of biopharmaceutical royalties and a financier of innovation. With a market..

Nuvalent, Inc. (NUVL) Stock Analysis: Riding High on Analyst Confidence with 46.98% Upside Potential

Nuvalent, Inc. (NASDAQ: NUVL) is making waves in the biotechnology sector, capturing investor attention with its ambitious pursuit of innovative cancer therapies and a remarkable 46.98% potential upside. As a..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: A Compelling 86.73% Potential Upside in the Medical Device Sector

iRhythm Holdings, Inc. (NASDAQ: IRTC) is positioned as a noteworthy player in the healthcare sector, particularly within the medical devices industry. The company specializes in digital healthcare solutions, with a..

Waystar Holding Corp. (WAY) Stock Analysis: Navigating a 52.21% Potential Upside with Robust Revenue Growth

Waystar Holding Corp. (WAY), a pivotal player in the Healthcare sector specializing in Health Information Services, presents a compelling case for investors seeking opportunities in the healthcare technology landscape. With..

Fresenius Medical Care AG (FMS) Stock Analysis: Unpacking the 18.65% Potential Upside

Fresenius Medical Care AG (NYSE: FMS), a key player in the healthcare sector, stands as a global leader in providing dialysis and related services. Headquartered in Bad Homburg, Germany, this..

Stryker Corporation (SYK) Stock Analysis: Evaluating a 26% Potential Upside in the Medical Device Sector

For investors navigating the healthcare sector, Stryker Corporation (NYSE: SYK) represents a compelling opportunity with a potential upside of over 26%, according to analyst ratings. As a significant player in..

Danaher Corporation (DHR) Stock Analysis: A 41% Upside Potential for Healthcare Investors

Investors looking to capitalize on the healthcare sector should certainly pay attention to Danaher Corporation (NYSE: DHR). With a substantial market capitalization of $132.46 billion, this Washington D.C.-based giant operates..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Strong Buy Ratings and 45.82% Potential Upside

Merit Medical Systems, Inc. (NASDAQ: MMSI) is capturing investor attention with its substantial potential upside and a suite of strong buy ratings from analysts. This Utah-based healthcare company, specializing in..

Tempus AI, Inc. (TEM) Stock Analysis: Exploring a Promising 55.92% Potential Upside

Tempus AI, Inc. (NASDAQ: TEM) has captured the attention of investors with its significant growth potential, underscored by a remarkable 55.92% potential upside, according to analyst ratings. As a healthcare..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds